Blood clot risk - USFDA limits use of JnJ COVID vaccine Ruchika Sharma6 May 2022 12:54 PM ISTThe vaccine maker said it has updated the U.S. COVID-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS),...
Stop sale of counterfeit HIV drugs: J&J files plea against drug distributors, pharmacies Roshni Dhar29 April 2022 6:30 PM ISTJohnson & Johnson has filed a lawsuit against drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs,...
Health Bulletin 29/April/2022 Roshni Dhar29 April 2022 5:07 PM ISTHere are the top health stories for today:NMC officials facing CBI probe on allegations of giving approvals to medical colleges for cash: ReportThe...
Stop sale of counterfeit HIV drugs: JnJ files plea against drug distributors, pharmacies Ruchika Sharma28 April 2022 4:24 PM ISTJnJ said counterfeit bottles sometimes contained a different HIV drug than what was on the label, and in one case contained the powerful antipsychotic...
JnJ suspends sales forecast for COVID vaccine Ruchika Sharma20 April 2022 12:09 PM ISTJnJ said it now expects full-year adjusted profit forecast to be between $10.15 and $10.35 per share, lower than the prior forecast of $ 10.40 to $...
Poorer nations refuse millions of AstraZeneca COVID vaccines from COVAX: Document Ruchika Sharma17 April 2022 9:00 AM ISTCountries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson and Johnson, Pfizer...
Janssen first cell therapy CARVYKTI gets USFDA nod MD Bureau1 March 2022 3:08 PM ISTHorsham - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved...
USFDA to allow export of AstraZeneca COVID vaccine lots made at Emergent facility Ruchika Sharma20 Feb 2022 9:45 AM ISTNew Delhi: The U.S. Food and Drug Administration said on Friday it had found four batches of AstraZeneca Plc's COVID-19 vaccine manufactured at...
J&J unit proposes independent exam if it remains in bankruptcy Ruchika Sharma20 Feb 2022 9:00 AM ISTNew Delhi: A Johnson & Johnson subsidiary proposed on Friday that it would submit to an independent examination of the corporate...
Medical devices, prescription drugs boost JnJ earning in Q4 Ruchika Sharma27 Jan 2022 9:00 AM ISTWashington: Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the...
JnJ reaches USD 44 million opioid settlement with New Mexico Ruchika Sharma16 Jan 2022 10:30 AM ISTNew Delhi: Johnson & Johnson on Friday said it had agreed to pay $44 million to resolve claims that it fueled the opioid epidemic in New...
JnJ COVID booster 85 percent effective against Omicron hospitalisation: SAMRC Ruchika Sharma15 Jan 2022 11:00 AM ISTJohannesburg: A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for...
